MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Edwards Lifesciences Corporation Cash and Cash Equivalents 2011-2026 | EW
Annual Cash and Cash Equivalents Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.94 B | 3.05 B | 1.15 B | 773 M | 863 M | 1.18 B | 1.18 B | 714 M | 818 M | 930 M | 718 M | 654 M | 420 M | 311 M | 171 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.05 B | 171 M | 1.06 B |
Quarterly Cash and Cash Equivalents Edwards Lifesciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.69 B | 3.27 B | 3.14 B | 3.05 B | 3.68 B | 1.66 B | 1.23 B | 1.13 B | 1.41 B | 1.05 B | 876 M | 769 M | 1.25 B | 1.2 B | 1.04 B | 863 M | 1.52 B | 1.31 B | 1.17 B | 1.18 B | 1.18 B | 1.18 B | 1.18 B | 1.18 B | 1.18 B | 1.18 B | 1.18 B | 714 M | 714 M | 714 M | 714 M | 818 M | 818 M | 818 M | 818 M | 930 M | 930 M | 930 M | 930 M | 718 M | 718 M | 718 M | 718 M | 654 M | 654 M | 654 M | 654 M | 420 M | 420 M | 420 M | 420 M | 311 M | 311 M | 311 M | 311 M | 171 M | 171 M | 171 M | 171 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.68 B | 171 M | 1.03 B |
Cash and Cash Equivalents of other stocks in the Medical devices industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
142 K | - | 37.08 % | $ 85.7 M |  USA |
 |
Beyond Air
XAIR
|
4.66 M | $ 0.72 | 3.86 % | $ 48.7 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
239 M | - | - | $ 3.31 B | USA |
 |
Dynatronics Corporation
DYNT
|
326 K | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
36.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
19.2 M | - | -26.83 % | $ 2.62 M | USA |
 |
Xtant Medical Holdings
XTNT
|
6.2 M | $ 0.54 | -4.43 % | $ 72.2 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
526 M | $ 88.29 | -0.97 % | $ 17.9 B | USA |
 |
Allied Healthcare Products
AHPI
|
3.32 M | - | 3.58 % | $ 2.21 M | USA |
 |
Align Technology
ALGN
|
1.04 B | $ 165.93 | -6.43 % | $ 12.4 B | USA |
 |
Alphatec Holdings
ATEC
|
161 M | $ 10.9 | -5.43 % | $ 1.64 B | USA |
 |
Conformis
CFMS
|
48.7 M | - | - | $ 16.4 M | USA |
 |
Accuray Incorporated
ARAY
|
57.4 M | $ 0.39 | 4.51 % | $ 40.1 M | USA |
 |
Abbott Laboratories
ABT
|
8.52 B | $ 104.33 | -0.23 % | $ 182 B | USA |
 |
Cardiovascular Systems
CSII
|
66.4 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
16.2 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
57 M | - | - | $ 475 M | USA |
 |
Boston Scientific Corporation
BSX
|
1.96 B | $ 69.42 | -1.07 % | $ 103 B | USA |
 |
Avinger
AVGR
|
5.28 M | - | -20.74 % | $ 369 K | USA |
 |
CONMED Corporation
CNMD
|
40.8 M | $ 34.68 | -5.35 % | $ 1.08 B | USA |
 |
NanoVibronix
NAOV
|
752 K | - | - | $ 1.08 M | USA |
 |
Neovasc
NVCN
|
51.5 M | - | - | $ 111 M |  Canada |
 |
Cytosorbents Corporation
CTSO
|
3.28 M | $ 0.6 | -0.18 % | $ 32.7 M | USA |
 |
Aethlon Medical
AEMD
|
5.5 M | $ 2.14 | -5.73 % | $ 3.34 M | USA |
 |
BIOLASE
BIOL
|
6.57 M | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
106 M | $ 11.11 | -2.63 % | $ 1.5 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
19.6 M | $ 15.65 | -4.31 % | $ 367 M | USA |
 |
Invacare Corporation
IVC
|
58.8 M | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
15.9 M | - | 10.0 % | $ 610 K | USA |
 |
Myomo
MYO
|
14.1 M | $ 0.67 | -1.26 % | $ 28 M | USA |
 |
Penumbra
PEN
|
187 M | $ 335.28 | -0.34 % | $ 13 B | USA |
 |
Inspire Medical Systems
INSP
|
105 M | $ 49.77 | -1.35 % | $ 1.46 B | USA |
 |
Pulmonx Corporation
LUNG
|
69.8 M | $ 1.17 | -5.65 % | $ 47.6 M | USA |
 |
Cutera
CUTR
|
144 M | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
NuVasive
NUVA
|
249 M | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
94.5 M | - | - | $ 217 M | USA |
 |
Surgalign Holdings
SRGA
|
16.3 M | - | -32.98 % | $ 1.68 M | USA |
 |
STRATA Skin Sciences
SSKN
|
5.43 M | - | - | $ 6.6 M | USA |